BFS
AXSM icon

Bare Financial Services’s Axsome Therapeutics AXSM Stock Holding History

Bare Financial Services’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.7K Hold
16
– – ﹤0.01% 879
2025
Q4 		$2.92K Sell
16
-5
-24% -$698 ﹤0.01% 736
2025
Q3 		$2.55K Buy
21
+11
+110% +$1.24K ﹤0.01% 751
2025
Q2 		$1.04K Buy
+10
New +$1.06K ﹤0.01% 912

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bare Financial Services's AXSM Position: Q1 2026 in Review

Bare Financial Services held its Axsome Therapeutics (AXSM) position steady in Q1 2026 at 16 shares worth $2.7K. The position accounts for ﹤0.01% of the portfolio, ranked #879.

Bare Financial Services first reported a position in AXSM in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.92K in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Bare Financial Services held 16 shares of Axsome Therapeutics worth $2.7K as of Q1 2026.
  • Bare Financial Services left its Axsome Therapeutics share count unchanged in Q1 2026.
  • Axsome Therapeutics made up ﹤0.01% of Bare Financial Services's portfolio in Q1 2026, its #879 holding.
  • Bare Financial Services first reported a position in Axsome Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Bare Financial Services's Axsome Therapeutics position peaked at $2.92K in Q4 2025.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Bare Financial Services's 13F filing for Q1 2026, filed 14 May 2026.